AR094296A1 - Composicion inmunogenica que comprende antigenos de mycoplasma - Google Patents
Composicion inmunogenica que comprende antigenos de mycoplasmaInfo
- Publication number
- AR094296A1 AR094296A1 ARP130105051A ARP130105051A AR094296A1 AR 094296 A1 AR094296 A1 AR 094296A1 AR P130105051 A ARP130105051 A AR P130105051A AR P130105051 A ARP130105051 A AR P130105051A AR 094296 A1 AR094296 A1 AR 094296A1
- Authority
- AR
- Argentina
- Prior art keywords
- immunogenic composition
- antigens
- group
- hyosynoviae
- hyorhinis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
Una composición inmunogénica que comprende: a) uno o más antígenos de M. hyorhinis y uno o más antígenos de M. hyosynoviae; y b) un portador aceptable desde el punto de vista farmacéutico. Además, una composición inmunogénica que comprende a) uno o más antígenos de Mycoplasma de bacterias de Mycoplasma seleccionadas del grupo que consiste en M. hyorhinis, M. hyopneumoniae y M. hyosynoviae; y b) uno o más componentes de un sistema de células eucarióticas. Además, una composición inmunogénica obtenida mediante un método que comprende a) cultivar bacterias de Mycoplasma seleccionadas del grupo que consiste en M. hyorhinis, M. hyopneumoniae y M. hyosynoviae en un sistema de células eucarióticas con una cantidad reducida de suero; b) obtener un antígeno de las bacterias de Mycoplasma; y c) agregar un portador aceptable desde el punto de vista farmacéutico. Reivindicación 39: Un método para inmunizar a un sujeto, caracterizado porque comprende administrarle al sujeto una composición inmunogénica de acuerdo con cualquiera de las reivindicaciones 1 a 38. Reivindicación 42: El método de acuerdo con cualquiera de las reivindicaciones 18 a 24, caracterizado porque el método genera una mejora en un parámetro de eficacia seleccionado del grupo que consiste en una duración más corta de la bacteremia, una carga bacteriana más baja o combinaciones de ambas, en comparación con un sujeto de un grupo de control no inmunizado de la misma especie.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261747026P | 2012-12-28 | 2012-12-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR094296A1 true AR094296A1 (es) | 2015-07-22 |
Family
ID=49956440
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP130105051A AR094296A1 (es) | 2012-12-28 | 2013-12-27 | Composicion inmunogenica que comprende antigenos de mycoplasma |
Country Status (20)
Country | Link |
---|---|
US (2) | US9878027B2 (es) |
EP (2) | EP2938356B1 (es) |
JP (2) | JP6195630B2 (es) |
KR (1) | KR102355614B1 (es) |
CN (2) | CN110227151B (es) |
AR (1) | AR094296A1 (es) |
AU (2) | AU2013370982C9 (es) |
BR (1) | BR112015015199B1 (es) |
CA (1) | CA2896293C (es) |
CL (1) | CL2015001659A1 (es) |
DK (1) | DK2938356T3 (es) |
EA (1) | EA038206B1 (es) |
ES (1) | ES2808673T3 (es) |
MX (1) | MX2015007729A (es) |
MY (1) | MY174818A (es) |
PH (1) | PH12015501335A1 (es) |
SG (1) | SG11201505086QA (es) |
TW (1) | TWI633890B (es) |
UA (1) | UA121097C2 (es) |
WO (1) | WO2014105671A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2013370982C9 (en) * | 2012-12-28 | 2019-01-24 | Boehringer Ingelheim Vetmedica Gmbh | Immunogenic composition comprising mycoplasma antigens |
WO2014105672A1 (en) | 2012-12-28 | 2014-07-03 | Boehringer Ingelheim Vetmedica Gmbh | Method of making a mycoplasma vaccine |
CN104730256B (zh) * | 2015-04-03 | 2016-05-04 | 江苏省农业科学院 | 用于检测支原体抗体的组合物及其应用 |
CN113444157B (zh) * | 2021-06-23 | 2022-05-13 | 湖北省农业科学院畜牧兽医研究所 | 猪鼻支原体外膜蛋白Mhr_0461在制备猪鼻支原体或其抗体检测试剂盒中的应用 |
CN113461791B (zh) * | 2021-06-23 | 2022-05-03 | 湖北省农业科学院畜牧兽医研究所 | 猪鼻支原体外膜蛋白Mhr_0493在制备猪鼻支原体或其抗体检测试剂盒中的应用 |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
GB1074920A (en) | 1965-04-21 | 1967-07-05 | Pfizer & Co C | Growth medium for mycoplasma pneumoniae and vaccine production |
ES343655A1 (es) | 1966-07-11 | 1968-09-01 | Research Corp | Metodo para la preparacion de un inoculo para aves de co- rral. |
JPS5540568B2 (es) * | 1972-10-05 | 1980-10-18 | ||
US5338543A (en) * | 1992-02-27 | 1994-08-16 | Ambico, Inc. | Thimerosal inactivated mycoplasma hyopneumoniae vaccine |
US6537552B1 (en) * | 1999-10-19 | 2003-03-25 | Iowa State University Research Foundation | Vaccine adjuvant |
US6825036B2 (en) | 2000-03-03 | 2004-11-30 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell |
US7018638B2 (en) * | 2000-12-19 | 2006-03-28 | Wyeth | Mycoplasma hyopneumoniae bacterin vaccine |
MY129765A (en) * | 2000-12-19 | 2007-04-30 | Wyeth Corp | Improved mycoplasma hyopneumoniae bacterin vaccine |
ES2550458T3 (es) * | 2001-07-02 | 2015-11-10 | Zoetis Services Llc | Vacuna monodosis con Mycoplasma hyopneumoniae |
MXPA03011924A (es) * | 2001-07-02 | 2004-03-26 | Pfizer Prod Inc | Vacuna de micoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado. |
TWI238721B (en) * | 2003-06-20 | 2005-09-01 | Animal Technology Inst Taiwan | Swine enzootic vaccine, its producing method and usage |
WO2006056841A1 (en) * | 2004-11-24 | 2006-06-01 | Pharmacia & Upjohn Company Llc | Multiple-strain mycoplasma hyopneumoniae vaccines |
EP1846223A4 (en) * | 2005-02-09 | 2012-05-30 | Magna Int Inc | METHOD FOR PRODUCING A SEMISTRUCTURAL PLATE |
EP1862537B1 (en) | 2005-03-10 | 2013-05-08 | Kyoritsu Seiyaku Corporation | Cell line culturable without aminal-derived component, method for establishment thereof, method for production of virus using the cell line and method for production of vaccine |
US20070009545A1 (en) * | 2005-07-07 | 2007-01-11 | Joachim Frey | Mycoplasma subunit vaccine |
KR101464783B1 (ko) * | 2006-09-15 | 2014-11-26 | 메디뮨 엘엘씨 | 높은 역가로 바이러스 증식을 지원하는 mdck 세포주 및 이를 이용한 생물반응기 공정 |
US20090068231A1 (en) * | 2007-09-11 | 2009-03-12 | Wyeth | Live attenuated mycoplasma strains |
CL2008003202A1 (es) * | 2007-10-29 | 2009-11-27 | Boehringer Ingelheim Vetmedica Inc | Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta. |
WO2009061798A1 (en) | 2007-11-06 | 2009-05-14 | Wyeth | Mycoplasma hyopneumoniae avirulent -adjuvanted live vaccine |
US20090317423A1 (en) * | 2008-01-23 | 2009-12-24 | Boehringer Ingelheim Vetmedica, Inc. | Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions |
US8444989B1 (en) * | 2008-04-18 | 2013-05-21 | Boehringer Ingelheim Vetmedica Gmbh | One dose vaccination against mycoplasma infections of pigs |
WO2009142086A1 (ja) * | 2008-05-23 | 2009-11-26 | 学校法人久留米大学 | マイコプラズマ感染症用ワクチン組成物 |
US8580280B2 (en) * | 2008-06-27 | 2013-11-12 | Zoetis Llc | Adjuvant compositions |
PE20120909A1 (es) | 2009-05-19 | 2012-08-19 | Bioproperties Pty Ltd | Cepa de vacuna de mycoplasma hyopneumoniae sensible a la temperatura y usos de la misma |
US20110150770A1 (en) * | 2009-12-18 | 2011-06-23 | Boehringer Ingelheim Vetmedica, Inc. | Multivalent vaccine against porcine teschovirus and other disease causing organisms in swine |
AT509622A1 (de) * | 2010-04-08 | 2011-10-15 | Greiner Bio One Gmbh | Verfahren und kit zur trennung viraler und prokaryontischer von eukaryontischen nukleinsäuren |
CN102258776B (zh) | 2011-07-07 | 2013-07-10 | 普莱柯生物工程股份有限公司 | 猪肺炎支原体、猪鼻支原体二联灭活疫苗及其制备方法 |
UA114503C2 (uk) * | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv та mycoplasma hyopneumoniae |
UA114504C2 (uk) * | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs |
US9120859B2 (en) * | 2012-04-04 | 2015-09-01 | Zoetis Services Llc | Mycoplasma hyopneumoniae vaccine |
WO2014105672A1 (en) * | 2012-12-28 | 2014-07-03 | Boehringer Ingelheim Vetmedica Gmbh | Method of making a mycoplasma vaccine |
AU2013370982C9 (en) * | 2012-12-28 | 2019-01-24 | Boehringer Ingelheim Vetmedica Gmbh | Immunogenic composition comprising mycoplasma antigens |
CN105764525A (zh) * | 2013-09-19 | 2016-07-13 | 硕腾服务有限责任公司 | 油基佐剂 |
EA201691993A1 (ru) * | 2014-04-03 | 2017-02-28 | Бёрингер Ингельхайм Ветмедика, Инк. | Вакцина к вирусу эпидемической диареи свиней |
-
2013
- 2013-12-20 AU AU2013370982A patent/AU2013370982C9/en not_active Ceased
- 2013-12-20 MX MX2015007729A patent/MX2015007729A/es active IP Right Grant
- 2013-12-20 BR BR112015015199-0A patent/BR112015015199B1/pt active IP Right Grant
- 2013-12-20 MY MYPI2015001620A patent/MY174818A/en unknown
- 2013-12-20 EP EP13821324.4A patent/EP2938356B1/en active Active
- 2013-12-20 ES ES13821324T patent/ES2808673T3/es active Active
- 2013-12-20 JP JP2015550684A patent/JP6195630B2/ja active Active
- 2013-12-20 US US14/135,791 patent/US9878027B2/en active Active
- 2013-12-20 UA UAA201507462A patent/UA121097C2/uk unknown
- 2013-12-20 EA EA201500700A patent/EA038206B1/ru unknown
- 2013-12-20 DK DK13821324.4T patent/DK2938356T3/da active
- 2013-12-20 SG SG11201505086QA patent/SG11201505086QA/en unknown
- 2013-12-20 CN CN201910422717.8A patent/CN110227151B/zh active Active
- 2013-12-20 CN CN201380065991.5A patent/CN104981252B/zh active Active
- 2013-12-20 EP EP20160539.1A patent/EP3730148A3/en active Pending
- 2013-12-20 WO PCT/US2013/076803 patent/WO2014105671A1/en active Application Filing
- 2013-12-20 CA CA2896293A patent/CA2896293C/en active Active
- 2013-12-20 KR KR1020157020445A patent/KR102355614B1/ko active IP Right Grant
- 2013-12-27 AR ARP130105051A patent/AR094296A1/es unknown
- 2013-12-27 TW TW102148878A patent/TWI633890B/zh active
-
2015
- 2015-06-12 CL CL2015001659A patent/CL2015001659A1/es unknown
- 2015-06-15 PH PH12015501335A patent/PH12015501335A1/en unknown
-
2017
- 2017-06-30 JP JP2017129051A patent/JP6456437B2/ja active Active
- 2017-12-19 US US15/846,975 patent/US10758602B2/en active Active
-
2018
- 2018-04-18 AU AU2018202698A patent/AU2018202698B2/en not_active Ceased
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR124676A2 (es) | Formulación farmacéutica que comprende una droga biofarmacéutica | |
MX2013013111A (es) | Composicion inmunogenica que presenta antigeno multiple, y metodos y usos de la misma. | |
EA201890942A1 (ru) | Мультивалентные вакцины с синтетическими наноносителями | |
MY166792A (en) | Mycoplasma Hyopneumoniae Vaccine | |
MX2013012165A (es) | Composicion y metodo para mejorar una respuesta inmune. | |
CO6511229A2 (es) | Metodos para reducir la actividad viricida en composiciones pcv-2 y composiciones pcv-2 con una inmunogeicidad mejorada | |
MX2019008065A (es) | Composiciones que comprenden anticuerpos anti-cd38 y lenalidomida. | |
AR090903A1 (es) | Anticuerpos e inmunoconjugados anti-pmel17 | |
EA201391602A1 (ru) | Контролируемое высвобождение иммунодепрессантов из синтетических наноносителей | |
BR112016022814A8 (pt) | composição farmacêutica e seu método de preparação, ácido nucleico, e dispositivo médico ou kit médico | |
JO3772B1 (ar) | صيغة جسم مضاد لـ cgrp | |
AR094296A1 (es) | Composicion inmunogenica que comprende antigenos de mycoplasma | |
AR101455A1 (es) | Molécula portadora | |
MX347020B (es) | Anticuerpo contra el csf-1r. | |
CY1117214T1 (el) | Συνθεση για ελεγχομενη διεγερση των ωοθηκων | |
MX338078B (es) | Cristales de anticuerpos anti-esclerostina y formulaciones de los mismos. | |
ES2738100T3 (es) | Método de fabricación de una vacuna contra micoplasma | |
CO6751260A2 (es) | Vacunas basadas en omv contra infecciones por burkholderia | |
MX354924B (es) | Molecula portadora que comprende un antigeno spr0096 y un spr2021. | |
CO6361948A2 (es) | Uso de antigeno de mycoplasma bovis | |
MY175418A (en) | Compositions comprising anti-cd38 antibodies and carfilzomib | |
EA201890747A1 (ru) | Способы лечения воспалительных заболеваний | |
NZ701463A (en) | Anti-phytopathogenic composition | |
MX357061B (es) | Diseño de inmunogenos a base de linaje de celulas b con animales humanizados. | |
BR112015032468A2 (pt) | vacina para disenteria suína |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |